title: Iodine-induced hyperthyroidism--an epidemiological survey several years after institution of iodine prophylaxis in Poland.
abstract: In 1997, the obligatory model of iodine prophylaxis was introduced in Poland in order to correct the existing status of mild and/or moderate iodine deficiency. In order to monitor possible side-effects of increased iodine supply, studies on iodine-induced hyperthyroidism were initiated by establishing several regional registers of hyperthyroidism. In the present paper, the results of a two-year monitoring (2000-2001) have been summarized. There are no epidemiological data on hyperthyroidism prior to starting the iodine prophylaxis, but the obtained current data are comparable to observations in other countries, made after iodine supplementation. The incidence of iodine-induced hyperthyroidism did not exceed the acceptable level, thus confirming--together with previous observations on the effectiveness of iodine prophylaxis--the adequacy of applied dose of KI (30 microg/kg NaCl), used for salt iodization in Poland.
authors.affiliation: Department of Thyroidology, Medical University of Lódź, Poland. alewin@csk.am.lodz.pl
authors.forename: A
authors.initials: A
authors.lastname: Lewiński
authors.forename: Z
authors.initials: Z
authors.lastname: Szybiński
authors.forename: E
authors.initials: E
authors.lastname: Bandurska-Stankiewicz
authors.forename: M
authors.initials: M
authors.lastname: Grzywa
authors.forename: A
authors.initials: A
authors.lastname: Karwowska
authors.forename: I
authors.initials: I
authors.lastname: Kinalska
authors.forename: A
authors.initials: A
authors.lastname: Kowalska
authors.forename: J
authors.initials: J
authors.lastname: Makarewicz
authors.forename: J
authors.initials: J
authors.lastname: Nauman
authors.forename: D
authors.initials: D
authors.lastname: Słowińska-Klencka
authors.forename: J
authors.initials: J
authors.lastname: Sowiński
authors.forename: A
authors.initials: A
authors.lastname: Syrenicz
authors.forename: A
authors.initials: A
authors.lastname: Zonenberg
authors.forename: B
authors.initials: B
authors.lastname: Huszno
authors.forename: M
authors.initials: M
authors.lastname: Klencki
mesh_terms: D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000032:analysis; D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D006306:Health Surveys; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced* / Q000453:epidemiology* / Q000276:immunology / Q000652:urine; D015994:Incidence; D007453:Iodide Peroxidase / Q000276:immunology; D007455:Iodine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use* / Q000652:urine; D008875:Middle Aged; D011044:Poland / Q000453:epidemiology; D011315:Preventive Medicine; D011877:Radionuclide Imaging; D013954:Thyroglobulin / Q000276:immunology; D013961:Thyroid Gland / Q000000981:diagnostic imaging / Q000473:pathology; D014463:Ultrasonography
chemical_list: D001323:Autoantibodies; D013954:Thyroglobulin; D007455:Iodine; D007453:Iodide Peroxidase